County of Ventura
County of Ventura was paid $47.73M by Medicaid between Jan 2018 and Dec 2024, across 150 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 80% of everything it billed.
SIMI VALLEY, CA 93065
Next to other Federally Qualified Health Center (FQHC) providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 106,190 | $5.59M | |
| 2019 | 126,230 | $6.65M | |
| 2020 | 142,743 | $7.23M | |
| 2021 | 145,580 | $7.52M | |
| 2022 | 120,970 | $6.09M | |
| 2023 | 143,820 | $7.34M | |
| 2024incomplete | 122,493 | $7.30M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 80% | 257,554 | 225,595 | $38.04M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.1% | 220,366 | 192,523 | $1.94M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.1% | 111,088 | 98,574 | $1.47M |
| 59425 | <1% | 5,522 | 3,520 | $415K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 12,357 | 12,308 | $361K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 6,133 | 6,089 | $323K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 8,814 | 8,802 | $312K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 5,093 | 5,077 | $261K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 2,898 | 2,886 | $250K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 6,956 | 6,917 | $248K |
| 97802 | <1% | 3,291 | 3,266 | $198K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 2,431 | 2,381 | $195K |
138 more codes
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 7,667 | $192K |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 8,554 | $182K |
| 90686 | <1% | 17,182 | $171K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 1,689 | $150K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 5,745 | $143K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 2,006 | $135K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 2,551 | $135K |
| 90750 | <1% | 824 | $130K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,411 | $122K |
| 99406 | <1% | 12,794 | $114K | |
| 90715 | <1% | 4,088 | $113K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 745 | $111K |
| 99174 | <1% | 2,809 | $103K | |
| 92250 | <1% | 2,042 | $97K | |
| 92551 | <1% | 19,243 | $97K | |
| 97803 | <1% | 2,652 | $92K | |
| 90670 | <1% | 5,936 | $79K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 10,094 | $76K |
| 99188 | <1% | 3,734 | $66K | |
| 0002A | <1% | 1,142 | $60K | |
| 90651 | <1% | 3,060 | $57K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 9,037 | $55K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 9,073 | $54K |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 2,109 | $53K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,086 | $46K |
| 95886 | <1% | 752 | $46K | |
| 0001A | <1% | 857 | $45K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 5,397 | $43K |
| J3490 | Unclassified drugs | <1% | 1,736 | $43K |
| G0467 | Community health center visit, returning patient | <1% | 17,873 | $40K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 2,597 | $37K |
| 90633 | <1% | 4,309 | $32K | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 383 | $31K |
| 17110 | <1% | 274 | $31K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,567 | $29K |
| 90647 | <1% | 4,281 | $29K | |
| 0072A | <1% | 531 | $28K | |
| 90723 | <1% | 4,200 | $28K | |
| 0064A | <1% | 538 | $28K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,148 | $27K |
| 90716 | <1% | 1,896 | $27K | |
| 0071A | <1% | 503 | $26K | |
| 90734 | <1% | 2,117 | $25K | |
| 0969 | <1% | 371 | $25K | |
| 90707 | <1% | 1,782 | $24K | |
| 90837 | Psychotherapy session, about an hour | <1% | 926 | $22K |
| 99243 | <1% | 323 | $22K | |
| 82274 | <1% | 1,177 | $20K | |
| G9920 | Screening performed and negative | <1% | 7,960 | $20K |
| 90710 | <1% | 1,619 | $20K | |
| 81025 | <1% | 6,296 | $19K | |
| 90680 | <1% | 2,393 | $19K | |
| 0004A | <1% | 339 | $18K | |
| 90677 | <1% | 863 | $17K | |
| 81002 | <1% | 16,736 | $17K | |
| 90700 | <1% | 1,711 | $16K | |
| 73562 | <1% | 711 | $15K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 83 | $15K |
| 90696 | <1% | 1,454 | $14K | |
| 73030 | <1% | 553 | $12K | |
| 99385 | <1% | 127 | $12K | |
| 99245 | <1% | 93 | $12K | |
| 90662 | <1% | 523 | $11K | |
| 59430 | <1% | 138 | $11K | |
| 73630 | <1% | 523 | $11K | |
| 72100 | <1% | 405 | $10K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 734 | $10K |
| 90688 | <1% | 622 | $7K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,006 | $6K |
| 90681 | <1% | 991 | $6K | |
| 0012A | <1% | 112 | $6K | |
| 99173 | <1% | 9,078 | $6K | |
| 96127 | <1% | 1,286 | $5K | |
| 90682 | <1% | 75 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 368 | $4K |
| 0003A | <1% | 67 | $4K | |
| 90697 | <1% | 534 | $3K | |
| 86580 | <1% | 710 | $3K | |
| 90685 | <1% | 264 | $3K | |
| 0011A | <1% | 49 | $3K | |
| 99386 | <1% | 16 | $3K | |
| 99241 | <1% | 55 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 17 | $2K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 78 | $2K |
| 0761 | <1% | 62 | $2K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 38 | $2K |
| 93226 | <1% | 24 | $2K | |
| 73610 | <1% | 79 | $2K | |
| 72110 | <1% | 49 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 240 | $1K |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 132 | $1K |
| 82948 | <1% | 703 | $1K | |
| 0054A | <1% | 17 | $1K | |
| 90746 | <1% | 26 | $1K | |
| 96156 | <1% | 38 | $1K | |
| 90674 | <1% | 109 | $1K | |
| 99384 | <1% | 27 | $1K | |
| 20610 | <1% | 25 | $966.21 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 13 | $900.51 |
| 69209 | <1% | 63 | $795.10 | |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | <1% | 140 | $788.78 |
| 59025 | Fetal non-stress test | <1% | 27 | $777.48 |
| 99401 | <1% | 123 | $755.58 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 117 | $746.39 |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 15 | $740.55 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 21 | $603.54 |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 28 | $571.00 |
| 73502 | <1% | 14 | $471.82 | |
| H0049 | Alcohol and/or drug screening | <1% | 14 | $416.40 |
| 93227 | <1% | 13 | $405.05 | |
| 73620 | <1% | 28 | $369.20 | |
| 73560 | <1% | 25 | $347.29 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 44 | $326.52 |
| 94664 | <1% | 32 | $309.79 | |
| D1206 | Topical application of fluoride varnish | <1% | 13 | $302.40 |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 37 | $298.78 |
| 90671 | <1% | 32 | $288.00 | |
| 69210 | <1% | 79 | $284.68 | |
| 77077 | <1% | 12 | $276.97 | |
| 73110 | <1% | 13 | $262.98 | |
| 72040 | <1% | 12 | $257.64 | |
| 90713 | <1% | 26 | $245.09 | |
| A4649 | Surgical supply; miscellaneous | <1% | 104 | $165.83 |
| 90744 | <1% | 14 | $154.63 | |
| 85018 | <1% | 55 | $132.85 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 203 | $84.30 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 15 | $2.50 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 13 | $0.30 |
| Z1034 | 0% | 3,766 | $0.00 | |
| 90656 | 0% | 413 | $0.00 | |
| Z6410 | 0% | 188 | $0.00 | |
| J7609 | Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg | 0% | 31 | $0.00 |
| 90480 | 0% | 12 | $0.00 | |
| 0636 | 0% | 17 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 12 | $0.00 |
| Z1032 | 0% | 12 | $0.00 | |
| Z6400 | 0% | 745 | $0.00 | |
| 91322 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| County of Ventura | Ventura, CA | $136.15M |
| County of Ventura | Ventura, CA | $32.44M |
| County of Ventura | Oxnard, CA | $21.57M |
| County of Ventura | Thousand Oaks, CA | $17.77M |
| County of Ventura | Oxnard, CA | $17.55M |
| County of Ventura | Oxnard, CA | $15.99M |
| County of Ventura | Ventura, CA | $14.53M |
| County of Ventura | Santa Paula, CA | $12.56M |
| County of Ventura | Oxnard, CA | $12.44M |
| County of Ventura | Oxnard, CA | $9.75M |
| County of Ventura | Moorpark, CA | $7.20M |
| County of Ventura | Camarillo, CA | $5.53M |
| County of Ventura | Fillmore, CA | $5.01M |
| County of Ventura | Santa Paula, CA | $3.83M |
| County of Ventura | Oxnard, CA | $618K |
| County of Ventura | Ventura, CA | $380K |
| County of Ventura | Oxnard, CA | $24K |
| County of Ventura | Oxnard, CA | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.